NCT02134652

Brief Summary

The purpose of this study is determine the ability of bedide ultrasound performed in the Emergency Department and Outpatient Department can predict the severity of disease during a Dengue Fever outbreak in children, in Siem Reap, Cambodia. Our hypothesis is that the presence of gallbladder wall thickening and/or pleural effusions in children correlates with progression to Dengue hemorrhagic fever and Dengue shock. In addition, we hypothesize that sonographic imaging of pediatric patients presenting to the emergency department with a fever during a Dengue fever outbreak will change management and disposition.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2015

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 29, 2014

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 9, 2014

Completed
8 months until next milestone

Study Start

First participant enrolled

January 1, 2015

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
Last Updated

June 11, 2015

Status Verified

June 1, 2015

Enrollment Period

1.4 years

First QC Date

April 29, 2014

Last Update Submit

June 10, 2015

Conditions

Keywords

UltrasonographyWorld Health

Outcome Measures

Primary Outcomes (1)

  • Progression of Disease

    Changes in clinical course or progression of disease in patients with Dengue Fever or Dengue Hemorrhagic Fever

    Patients who are discharged from home will be contacted a maximum of 10 days after discharge to acquire follow up data. Those patients who are admitted to the hospital will monitored for the entirety of their hospital stay, an average of about 2 weeks.

Secondary Outcomes (1)

  • Clinical Care

    Patients will receive an ultrasound in the emergency department or outpatient department. Within 2 hours of study enrollment, the treating physician will be made aware of the test results and will be queried for changes in decision making.

Other Outcomes (1)

  • Disposition

    Patients will receive an ultrasound in the emergency department or outpatient department. Within 2 hours of study enrollment, the treating physician will be made aware of the test results and will be queried for decision to admit versus discharge.

Study Arms (1)

Suspected Dengue

Children with an acute febrile illness, and two of the following: headache, retro-orbital pain, myalgias, arthralgia, rash, hemorrhagic manifestations, or plasma leakage (i.e. shortness of breath, abdominal distention/pain) will all receive a diagnostic bedside ultrasound.

Other: diagnostic bedside ultrasound

Interventions

Patients enrolled in this study will undergo bedside ultrasound during their initial presentation to the emergency department. Ultrasound imaging protocols include the following: * FAST Exam - Standard images will be obtained using the abdominal transducer. Images include the following: 1) sub-xyphoid 2)right upper quadrant (with right thorax) 3)left upper quadrant (with left thorax) and 4) suprapubic * Right Upper Quadrant Exam - Standard images will be obtained using the abdominal transducer. Images include the following: 1) Long axis of the gallbladder 2) Transverse axis of the gallbladder fundus 3) Transverse axis of the gallbladder body and 4) Transverse axis of the gallbladder neck.

Suspected Dengue

Eligibility Criteria

Age3 Months - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Study subjects will include children 16 years or less, who present during the annual Dengue Fever outbreak with suspected Dengue fever. Subjects include children with an acute febrile illness, and two of the following: headache, retro-orbital pain, myalgias, arthralgia, rash, hemorrhagic manifestations, or plasma leakage (i.e. shortness of breath, abdominal distention/pain)

You may qualify if:

  • Age \>3 months and \<16 years
  • Clinical suspicion of dengue hemorrhagic fever. (Revised WHO Classification System)
  • Not a prisoner or ward of the state
  • Parents able and willing to give consent. Children older then 7 able and willing to give assent

You may not qualify if:

  • Allergic to Ultrasound gel
  • Prisoners or wards of the state
  • Unstable patients
  • Known pleural effusion, ascites, or gallbladder wall thickening.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Angkor Hospital for Children

Siem Reap, Cambodia

Location

MeSH Terms

Conditions

DengueDisease Progression

Condition Hierarchy (Ancestors)

Mosquito-Borne DiseasesVector Borne DiseasesInfectionsArbovirus InfectionsVirus DiseasesFlavivirus InfectionsFlaviviridae InfectionsRNA Virus InfectionsHemorrhagic Fevers, ViralDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Samuel D Licciardo, M.D.

    University of Massachusetts, Worcester

    PRINCIPAL INVESTIGATOR
  • Romolo Gaspari, M.D., Ph.D.

    University of Massachusetts, Worcester

    STUDY CHAIR
0

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 29, 2014

First Posted

May 9, 2014

Study Start

January 1, 2015

Primary Completion

June 1, 2016

Study Completion

June 1, 2016

Last Updated

June 11, 2015

Record last verified: 2015-06

Locations